E. Dale Abel

E. Dale Abel is a Professor and Department Chair at the David Geffen School of Medicine, University of California Los Angeles (UCLA). His work bridges cardiovascular research with metabolic disorders, focusing on diabetes-induced mitochondrial dysfunction and insulin signaling in cardiac health. Current research programs include modulating ROS via electromagnetic fields and mitochondrial dynamics in platelets.

• Education: MD and PhD in Molecular Medicine from University of Melbourne
• Training: Internship at Royal Melbourne Hospital; Fellowship at NIH

His research interests center on diabetic cardiomyopathy, mitochondrial bioenergetics, and metabolic reprogramming in heart disease. Recent studies explore:

• 2024 Cell paper on evolving diabetes pandemic
• 2022 Circulation Research work on macrophage glucose suppression
• 2021 mitochondrial stress adaptation in Autophagy and eLife

Scientific grants include:

• NIH R01HL157781 (2021-2025): Investigating MG53 in heart structure
• NIH R01DK125079 (2021-2026): Electromagnetic field therapy for diabetes
• NIH R01HL112413 (2015-2020): Cardiac insulin resistance mechanisms